Skip to Content
Merck
All Photos(1)

Documents

878100C

Avanti

C17-02:0 PC

Avanti Research™ - A Croda Brand 878100C

Synonym(s):

1-O-Heptadecyl-2-Acetoyl-sn-Glycero-3-Phosphocholine (C17 PAF)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C27H56NO7P
CAS Number:
93037-84-4
Molecular Weight:
537.71
UNSPSC Code:
12352211
NACRES:
NA.25

form

liquid

packaging

pkg of 1 × 1 mL (878100C-5mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 878100C

concentration

5 mg/mL (878100C-5mg)

shipped in

dry ice

storage temp.

−20°C

SMILES string

[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(C)=O)COCCCCCCCCCCCCCCCCC)=O

General description

C17-02:0 PC, also known as 1-O-heptadecyl-2-acetyl-sn-glycero-3-phosphocholine (C17 PAF) is a platelet activating factor containing ether-linked heptadecyl chain at the sn-1 position and an acetyl group at the sn-2 position.

Biochem/physiol Actions

Platelet-activating factor (PAF) acts as a lipid mediator and is involved in various inflammatory diseases.

Packaging

5 mL Clear Glass Sealed Ampule (878100C-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

Target Organs

Central nervous system

WGK

WGK 3

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Akira Sato et al.
European journal of pharmacology, 745, 46-51 (2014-12-03)
Platelet-activating factor (PAF) is a potent lipid mediator that is implicated in numerous inflammatory diseases. C-reactive protein (CRP) is an acute-phase plasma protein that increases rapidly and dramatically in response to inflammation. In this study, we investigated the effect of
Sunil A Nankar et al.
Biochimie, 95(6), 1196-1207 (2013-02-05)
Apolipoprotein-derived peptides are promising candidates for the treatment of various inflammatory conditions and the main mechanism proposed for the protective action of these peptides includes binding to pro-inflammatory lipid mediators with high affinity and facilitating their sequestration/metabolism/clearance in the body.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service